Cited by 455Migraine and Headache StudiesTraumatic Brain Injury ResearchPharmaceutical Practices and Patient Outcomes

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Medication-overuse headache: a worldwide problem

Diener, Hans-Christoph, Limmroth, Volker·2004·The Lancet Neurology

Open this paper in CoChat — free account

Abstract

Medication overuse and subsequent medication-overuse headache (MOH) is a growing problem worldwide. Epidemiological data suggest that up to 4% of the population overuse analgesics and other drugs for the treatment of pain conditions such as migraine and that about 1% of the general population in Europe, North America, and Asia have MOH. Recent clinical studies gave further insights in clinical and pharmacological features, such as critical monthly doses and frequencies. These features seem to vary significantly and depend on the primary headache disorder and the type of drug that is overused. Along with these findings the new international classification of headache disorders has now incorporated additional criteria and new headache entities that will facilitate the diagnosis of MOH. Withdrawal therapy is the only treatment for this disorder and clear restriction of monthly doses is the central requirement for successful prevention.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(04)00824-5

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The International Classification of Headache Disorders: 2nd edition
Olesen, J., Goadsby, P. J., & Steiner, T. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00590-8 · Cited by 5,046
Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study
Sorge, F., Simone, R. D., Marano, E., Nolano, M., Orefice, G., & Carrieri, P. B. (1988) · Cephalalgia · doi:10.1046/j.1468-2982.1988.0801001.x · Cited by 3,464
A Report on the Journal 2004
Goadsby, P. J. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00711.x · Cited by 2,381
Epidemiology of Tension-Type Headache
Schwartz, B. S. (1998) · JAMA · doi:10.1001/jama.279.5.381 · Cited by 762
Factors associated with the onset and remission of chronic daily headache in a population-based study
Scher, I., Stewart, F. W., Rícci, A., & Lipton, B. R. (2003) · Pain · doi:10.1016/s0304-3959(03)00293-8 · Cited by 714
Epidemiology of Chronic Daily Headache in the General Population
Castillo, J., Muñoz, P., Guitera, V., & Pascual, J. (1999) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1999.3903190.x · Cited by 711
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)—-Revision of Criteria for 8.2 Medication-Overuse Headache
Silberstein, S., Olesen, J., Bousser, M.-G., Diener, H.-C., Dodick, D., First, M., Goadsby, P., Göbel, H., Lainez, M., Lance, J., et al. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.00878.x · Cited by 517
Self-citation
Features of medication overuse headache following overuse of different acute headache drugs
Limmroth, V., Katsarava, Z., Fritsche, G., Przywara, S., & Diener, H. (2002) · Neurology · doi:10.1212/wnl.59.7.1011 · Cited by 391
Self-citation
Withdrawal Syndrome after the Double-Blind Cessation of Caffeine Consumption
Silverman, K., Evans, S. M., Strain, E. C., & Griffiths, R. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210153271601 · Cited by 380
Incidence and predictors for chronicity of headache in patients with episodic migraine
Katsarava, Z., Schneeweiß, S., Kurth, T., Kroener, U., Fritsche, G., Eikermann, A., Diener, H., & Limmroth, V. (2004) · Neurology · doi:10.1212/01.wnl.0000113747.18760.d2 · Cited by 375
Self-citation

Show all 82 references

Research works printed but not linked: 5

Moeschlin, 1957, Phenacetinsucht und Schäden, Schweiz Med Wochenschr, 87, 123
1988, . Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, Cephalalgia, 8, 1
Diener, 1988, Analgetikainduzierter Dauerkopfschmerz. Existiert eine kritische Dosis?, Arzneimitteltherapie, 6, 156
Newman, 1993, Hemicrania continua: 7 new cases and a literature review, Headache, 32, 267
Z Katsarava, M Müssig, A Dzagniza, G Fritsche, HC Diener, V Limmroth, Rate and predictors for relapses in medication overuse headache: a four year prospective study. Cephalalgia (in press).

Sorted by citations

Items 101–200 of 455

Headache and Migraine in Children with Sickle Cell Disease Are Associated with Lower Hemoglobin and Higher Pain Event Rates But Not Silent Cerebral Infarction
Dowling, M. M., Noetzel, M. J., Rodeghier, M., Quinn, C. T., Hirtz, D. G., Ichord, R., Kwiatkowski, J. L., Roach, E. S., Kirkham, F. J., Casella, J. F., et al. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.01.001 · Cited by 42
Drug-dependence behaviour and outcome of medication-overuse headache after treatment
Corbelli, I., Caproni, S., Eusebi, P., & Sarchielli, P. (2012) · The Journal of Headache and Pain · doi:10.1007/s10194-012-0492-z · Cited by 41
Medication Overuse Headaches
Abrams, B. M. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.12.007 · Cited by 41
Headache Characteristics and Clinical Features of Elderly Migraine Patients
de Rijk, P., Resseguier, N., & Donnet, A. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13247 · Cited by 40
In-patient versus out-patient withdrawal programmes for medication overuse headache: A 2-year randomized trial
Créac’h, C., Frappé, P., Cancade, M., Laurent, B., Peyron, R., Demarquay, G., & Navez, M. L. (2011) · Cephalalgia · doi:10.1177/0333102411412088 · Cited by 39
Medication-overuse headache in China: Clinical profile, and an evaluation of the ICHD-3 beta diagnostic criteria
Dong, Z., Chen, X., Steiner, T. J., Hou, L., Di, H., He, M., Dai, W., Pan, M., Zhang, M., Liu, R., et al. (2014) · Cephalalgia · doi:10.1177/0333102414552533 · Cited by 39
Preventing and treating medication overuse headache
Alstadhaug, K. B., Ofte, H. K., & Kristoffersen, E. S. (2017) · PAIN Reports · doi:10.1097/pr9.0000000000000612 · Cited by 39
A systematic review and critical appraisal of gene polymorphism association studies in medication-overuse headache
Cargnin, S., Viana, M., Sances, G., Tassorelli, C., & Terrazzino, S. (2017) · Cephalalgia · doi:10.1177/0333102417728244 · Cited by 39
Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience
Grazzi, L., & Usai, S. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2140-2 · Cited by 39
Medication-overuse headache in patients with cluster headache
Paemeleire, K., Evers, S., & Goadsby, P. J. (2008) · Current Pain and Headache Reports · doi:10.1007/s11916-008-0023-4 · Cited by 39
How Clinicians can Detect, Prevent and Treat Medication Overuse Headache
Dodick, D., & Silberstein, S. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01737.x · Cited by 39
Update on Chronic Daily Headache
Couch, J. R. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0104-7 · Cited by 38
Pain modulation is affected differently in medication-overuse headache and chronic myofascial pain – A multimodal MRI study
Michels, L., Christidi, F., Steiger, V. R., Sándor, P. S., Gantenbein, A. R., Landmann, G., Schreglmann, S. R., Kollias, S., & Riederer, F. (2016) · Cephalalgia · doi:10.1177/0333102416652625 · Cited by 38
Evaluation and treatment of medication-overuse headache: Russian experts’ guidelines
Tabeeva, G. R., Osipova, V. В., Filatova, E. G., Azimova, Y. É., Амелин, А. В., Artemenko, A. R., Vorobyeva, Y. D., Ekusheva, E. V., Koreshkina, M. I., Lebedeva, E. R., et al. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-1-4-13 · Cited by 38
Genomic expression patterns in medication overuse headaches
Hershey, A. D., Burdine, D., Kabbouche, M. A., & Powers, S. W. (2010) · Cephalalgia · doi:10.1177/0333102410373155 · Cited by 38
The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache
Lundqvist, C., Aaseth, K., Grande, R. B., Benth, J. Š., & Russell, M. B. (2010) · Pain · doi:10.1016/j.pain.2009.12.010 · Cited by 37
Best Practices for Patients With Chronic Migraine
Starling, A. J., & Dodick, D. W. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.01.010 · Cited by 37
Should we educate about the risks of medication overuse headache?
Lai, J. T. F., Dereix, J. D., Ganepola, R. P., Nightingale, P., Markey, K. A., Aveyard, P. N., & Sinclair, A. J. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-10 · Cited by 37
Prevalence of medication overuse headache in an interdisciplinary pain clinic
Schmid, C. W., Maurer, K., SCHMID, D. M., Alon, E., Spahn, D. R., Gantenbein, A. R., & Sándor, P. S. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-4 · Cited by 37
Psychological factors associated with failure of detoxification treatment in chronic headache associated with medication overuse
Bottiroli, S., Viana, M., Sances, G., Ghiotto, N., Guaschino, E., Galli, F., Vegni, E. A. M., Pazzi, S., Nappi, G., & Tassorelli, C. (2016) · Cephalalgia · doi:10.1177/0333102416631960 · Cited by 37
Gi-protein–coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming
Araldi, D., Ferrari, L. F., & Levine, J. D. (2016) · Pain · doi:10.1097/j.pain.0000000000000581 · Cited by 37
Sudden Caffeine Withdrawal Triggers Migraine—A Randomized Controlled Trial
Alstadhaug, K. B., Ofte, H. K., Müller, K. I., & Andreou, A. P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01002 · Cited by 42
Medicine use for headache in adolescence predicts medicine use for headache in young adulthood
Andersen, A., Holstein, B. E., Due, P., & Hansen, E. H. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1748 · Cited by 37
Triptan overuse in the Dutch general population: A nationwide pharmaco-epidemiology database analysis in 6.7 million people
Dekker, F., Wiendels, N. J., de Valk, V., van der Vliet, C., Neven, A. K., Assendelft, W. J., & Ferrari, M. D. (2011) · Cephalalgia · doi:10.1177/0333102411408626 · Cited by 36
Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact
Sokolovic, E., Riederer, F., Szucs, T., Agosti, R., & Sándor, P. S. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-29 · Cited by 35
Celecoxib vs Prednisone for the Treatment of Withdrawal Headache in Patients With Medication Overuse Headache: A Randomized, Double‐Blind Clinical Trial
Taghdiri, F., Togha, M., Jahromi, S. R., & Paknejad, S. M. H. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12487 · Cited by 35
A randomized controlled trial on medication-overuse headache: outcome after 1 and 4 years
Hagen, K., & Stovner, L. J. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01542.x · Cited by 35
Dependent Behavior in Patients with Medication-Overuse Headache
Fuh, J., & Wang, S. (2011) · Current Pain and Headache Reports · doi:10.1007/s11916-011-0240-0 · Cited by 35
Medication–overuse headache: pathophysiological insights
Calabresi, P., & Cupini, L. M. (2005) · The Journal of Headache and Pain · doi:10.1007/s10194-005-0184-z · Cited by 35
Clinical Features of Probable Medication-Overuse Headache: A Retrospective Study in Japan
Imai, N., Kitamura, E., Konishi, T., Suzuki, Y., Serizawa, M., & Okabe, T. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01389.x · Cited by 34
Management of migraine in Australian general practice
Stark, R. J., Valenti, L., & Miller, G. C. (2007) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01170.x · Cited by 34
Medication Overuse Headache
Rapoport, A. M. (2008) · CNS Drugs · doi:10.2165/0023210-200822120-00003 · Cited by 34
Young adolescents' use of medicine for headache: sources of supply, availability and accessibility at home
Holstein, B. E., Andersen, A., Krølner, R. F., Due, P., & Hansen, E. H. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1563 · Cited by 34
Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse
Ahmed, F., Zafar, H., Buture, A., & Khalil, M. (2015) · SpringerPlus · doi:10.1186/s40064-015-1386-8 · Cited by 33
Medication overuse headache
Katsarava, Z., Holle, D., & Diener, H. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0019-4 · Cited by 33
Self-citation
Prophylactic effects of asiaticoside-based standardized extract of Centella asiatica (L.) Urban leaves on experimental migraine: Involvement of 5HT1A/1B receptors
Bobade, V., Bodhankar, S. L., Aswar, U. M., Vishwaraman, M., & Thakurdesai, P. A. (2015) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(15)30014-5 · Cited by 33
Disability in Chronic Migraine With Medication Overuse: Treatment Effects at 3 Years
Andrasik, F., Grazzi, L., Usai, S., D’Amico, D., Kass, S. J., & Bussone, G. (2007) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.00861.x · Cited by 33
OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study
Aydınlar, E. I., Dikmen, P. Y., Kosak, S., & Kocaman, A. S. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0723-4 · Cited by 33
Medication overuse headache: a review of current evidence and management strategies
Kebede, Y. T., Mohammed, B. D., Tamene, B. A., Abebe, A. T., & Dhugasa, R. W. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2023.1194134 · Cited by 32
Chronic migraine: current concepts and ongoing treatments.
Negro, A., March, M. R., Fiorillo, M., & Martelletti, P. (2011) · PubMed · Cited by 32
Hints on Diagnosing and Treating Headache
May, A. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0299 · Cited by 31
Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting
Santoro, A., Fontana, A., Miscio, A. M., Zarrelli, M. M., Copetti, M., & Leone, M. A. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3054-y · Cited by 30
Hypnic headache and caffeine
Holle, D., & Obermann, M. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.100 · Cited by 29
Functional polymorphisms in COMT and SLC 6A4 genes influence the prognosis of patients with medication overuse headache after withdrawal therapy
Cargnin, S., Viana, M., Ghiotto, N., Bianchi, M., Sances, G., Tassorelli, C., Nappi, G., Canonico, P. L., Genazzani, A. A., & Terrazzino, S. (2014) · European Journal of Neurology · doi:10.1111/ene.12424 · Cited by 29
Triptan use in Italy: Insights from administrative databases
Cas, R. D., Nigro, A., Terrazzino, S., Sances, G., Viana, M., Tassorelli, C., Nappi, G., Cargnin, S., Pisterna, A., Traversa, G., et al. (2014) · Cephalalgia · doi:10.1177/0333102414550419 · Cited by 28
Twenty-five years of triptans – a nationwide population study
Davidsson, O. B., Olofsson, I. A., Kogelman, L. J. A., Andersen, M. A., Rostgaard, K., Hjalgrim, H., Olesen, J., & Hansen, T. F. (2021) · Cephalalgia · doi:10.1177/0333102421991809 · Cited by 28
Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine
Ailani, J., Rabany, L., Tamir, S., Ironi, A., & Starling, A. J. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2021.753736 · Cited by 28
An adapted Severity of Dependence Scale is valid for the detection of medication overuse: the Akershus study of chronic headache
Lundqvist, C., Benth, J. Š., Grande, R. B., Aaseth, K., & Russell, M. B. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03202.x · Cited by 28
Chronic Daily Headache with Medication Overuse: A Randomized Follow-Up by Neurologist or PCP
Bøe, M., Salvesen, R., & Mygland, Å. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01810.x · Cited by 28
Chronic migraine treatment: from OnabotulinumtoxinA onwards
Negro, A., Curto, M., Lionetto, L., Giamberardino, M. A., & Martelletti, P. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1200973 · Cited by 26
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications
Goadsby, P. J., Blumenfeld, A. M., Lipton, R. B., Dodick, D. W., Kalidas, K., Adams, A. M., Jakate, A. S., Liu, C., Szegedi, A., & Trugman, J. M. (2020) · Cephalalgia · doi:10.1177/0333102420970523 · Cited by 26
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Lipton, R. B., Dodick, D. W., Goadsby, P. J., Burstein, R., Adams, A. M., Lai, J., Yu, S. Y., Finnegan, M., Kuang, A. W., & Trugman, J. M. (2022) · Neurology · doi:10.1212/wnl.0000000000201031 · Cited by 26
A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities
Ljubisavljević, S., Ljubisavljevic, M., Damjanovic, R., & Kalinic, S. (2023) · Brain Sciences · doi:10.3390/brainsci13101408 · Cited by 29
A Qualitative Study On Patients With Chronic Migraine With Medication Overuse Headache: Comparing Frequent And Non‐Frequent Relapsers
Scaratti, C., Covelli, V., Guastafierro, E., Leonardi, M., Grazzi, L., Rizzoli, P. B., D’Amico, D., & Raggi, A. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13385 · Cited by 29
Screening And Behavioral Management: Medication Overuse Headache – The Complex Case
Lake, A. E. (2007) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.00971.x · Cited by 25
Therapie primärer chronischer Kopfschmerzen
Straube, A. M., May, A., Kropp, P. A., Katsarava, Z., Haag, G., Lampl, C., Sándor, P. S., Diener, H., & Evers, S. (2008) · Der Schmerz · doi:10.1007/s00482-008-0645-9 · Cited by 23
Self-citation
When should “chronic migraine” patients be considered “refractory” to pharmacological prophylaxis?
D’Amico, D., Leone, M., Grazzi, L., & Bussone, G. (2008) · Neurological Sciences · doi:10.1007/s10072-008-0888-3 · Cited by 26
Personality traits in chronic daily headache patients with and without psychiatric comorbidity: an observational study in a tertiary care headache center
Rausa, M., Cevoli, S., Sancisi, E., Grimaldi, D., Pollutri, G., Casoria, M., Grieco, D., Bisi, A., Cortelli, P., Pozzi, E., et al. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-22 · Cited by 24
Migraine and Migraines of Specialists: Perceptions and Management
Donnet, A., Becker, H., Allaf, B., & Lantéri‐Minet, M. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01660.x · Cited by 24
Device profile of the Nerivio™ for acute migraine treatment: overview of its efficacy and safety
Rapoport, A. M., & Lin, T. (2019) · Expert Review of Medical Devices · doi:10.1080/17434440.2019.1695599 · Cited by 24
The outcomes for nasal contact point surgeries in patients with unsatisfactory response to chronic daily headache medications
Abu-Samra, M., Gawad, O. A., & Agha, M. (2011) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-011-1590-2 · Cited by 24
Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine
Akerman, S., & Romero‐Reyes, M. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.827472 · Cited by 24
Headache in the world: public health and research priorities
Steiner, T. J. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.12.78 · Cited by 23
The role of personality, disability and physical activity in the development of medication-overuse headache: a prospective observational study
Mose, L. S., Pedersen, S. S., Debrabant, B., Jensen, R., & Gram, B. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0863-1 · Cited by 23
Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
Pijpers, J. A., Kies, D. A., van Zwet, E. W., Rosendaal, F. R., & Terwindt, G. M. (2022) · European Journal of Neurology · doi:10.1111/ene.15256 · Cited by 23
Sumatriptan: treatment across the full spectrum of migraine
Silberstein, S. D., & Marcus, D. A. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.810209 · Cited by 23
The Combined Effect of Acupuncture and Tanacetum parthenium on quality of life in women with headache: Randomised study
Ferro, E. C., Biagini, Â. P., da Silva, Í. E. F., da Silva, M. L., & da Silva, J. R. T. (2012) · Acupuncture in Medicine · doi:10.1136/acupmed-2012-010195 · Cited by 23
Cómo y cuándo derivar un paciente con cefalea secundaria y otros tipos de dolores craneofaciales desde Urgencias y Atención Primaria: recomendaciones del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología
Gago‐Veiga, A. B., de Terán, J. D., González-García, N., Oria, C. G., González‐Quintanilla, V., Mínguez‐Olaondo, A., Lasaosa, S. S., Romero, J. V., & Pozo‐Rosich, P. (2017) · Neurología · doi:10.1016/j.nrl.2017.08.002 · Cited by 23
Cortical and Subcortical Alterations in Medication Overuse Headache
Mehnert, J., Hebestreit, J. M., & May, A. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00499 · Cited by 23
Personality traits in migraine and medication‐overuse headache: A comparative study
Mose, L. S., Pedersen, S. S., Jensen, R., & Gram, B. (2019) · Acta Neurologica Scandinavica · doi:10.1111/ane.13111 · Cited by 23
Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy
Santoro, A., Copetti, M., Miscio, A. M., Leone, M. A., & Fontana, A. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04283-y · Cited by 23
Medication-Overuse Headache in Japan
Kanki, R., Nagaseki, Y., & Sakai, F. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01736.x · Cited by 23
Medication Overuse Headache in India
Ravishankar, K. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01731.x · Cited by 23
Medication-overuse headache: Description, treatment, and relapse prevention
Grazzi, L., & Andrasik, F. (2006) · Current Pain and Headache Reports · doi:10.1007/s11916-006-0012-4 · Cited by 23
Medication overuse headache is associated with elevated lipopolysaccharide binding protein and pro-inflammatory molecules in the bloodstream
Dağıdır, H. G., Topa, E., Vurallı, D., & Bolay, H. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01672-4 · Cited by 25
From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries
Allena, M., Katsarava, Z., & Nappi, G. (2009) · The Journal of Headache and Pain · doi:10.1007/s10194-009-0101-y · Cited by 22
The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline
Valguarnera, F., & Tanganelli, P. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0319-0 · Cited by 22
Pain Management Part II: Pharmacologic Management of Chronic Orofacial Pain
Ganzberg, S. I. (2010) · Anesthesia Progress · doi:10.2344/0003-3006-57.3.114 · Cited by 22
ID-Migraine™ questionnaire and accurate diagnosis of migraine
de Mattos, A. C. M. T., de Souza, J. A., Filho, P. F. M., Jurno, M. E., & Velarde, L. G. C. (2017) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170069 · Cited by 22
Real-world Experience with Remote Electrical Neuromodulation in the Acute Treatment of Migraine
Tepper, S. J., Lin, T., Montal, T., Ironi, A., & Dougherty, C. O. (2020) · Pain Medicine · doi:10.1093/pm/pnaa299 · Cited by 22
How to treat medication overuse headache
Diener, H. (2007) · Neurology · doi:10.1212/01.wnl.0000269324.27980.a9 · Cited by 22
Self-citation
Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine
Rapoport, A. M., Lin, T., & Tepper, S. J. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13669 · Cited by 21
Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
Gibler, R. C., Knestrick, K. E., Reidy, B. L., Lax, D. N., & Powers, S. W. (2022) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s334744 · Cited by 25
Cross-sectional, hospital-based analysis of headache types using ICHD-3 criteria in the Middle East, Asia, and Africa: the Head-MENAA study
Genç, H., Baykan, B. B., Bolay, H., Uludüz, D., Ünal-Çevik, I., Kissani, N., Luvsannorov, O., Togha, M., Özdemir, A. A., Özge, A., et al. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01555-8 · Cited by 24
Association of RAMP 1 rs 7590387 With the Risk of Migraine Transformation Into Medication Overuse Headache
Cargnin, S., Pautasso, C., Viana, M., Sances, G., Mittino, D., Cantello, R. M., Tassorelli, C., Nappi, G., & Terrazzino, S. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12559 · Cited by 21
Patient outcome in migraine prophylaxis: the role of psychopharmacological agents
Pompili, M. (2010) · Patient Related Outcome Measures · doi:10.2147/prom.s9742 · Cited by 21
Changes in anxiety and depression symptoms associated to the outcome of MOH: A post-hoc analysis of the Comoestas Project
Bottiroli, S., Allena, M., Sances, G., Icco, R. D., Avenali, M., Fadić, R., Katsarava, Z., Láinez, M. J. A., Goicochea, M. T., Jensen, R., et al. (2017) · Cephalalgia · doi:10.1177/0333102417704415 · Cited by 21
A Critical Evaluation on MOH Current Treatments
Negro, A., Curto, M., Lionetto, L., Guérzoni, S., Pini, L. A., & Martelletti, P. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0465-2 · Cited by 21
Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache
Cargnin, S., Viana, M., Sances, G., Bianchi, M., Ghiotto, N., Tassorelli, C., Nappi, G., Canonico, P. L., Genazzani, A. A., & Terrazzino, S. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1726-6 · Cited by 20
Chronic daily headache
Nappi, G., Perrotta, A., Rossi, P. D., & Sandrini, G. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.3.361 · Cited by 20
A Satisfaction Survey of Current Medicines Used for Migraine Therapy in China: Is Chinese Patent Medicine Effective Compared with Western Medicine for the Acute Treatment of Migraine?
Luo, N., Qi, W., Can, Z., Di, W., Lu, Y., Huang, Z., Sun, Y., Zhang, A., Huang, X., Tao, Y., et al. (2013) · Pain Medicine · doi:10.1111/pme.12277 · Cited by 19
Cortical Alterations in Medication‐Overuse Headache
Riederer, F., Schaer, M., Gantenbein, A. R., Luechinger, R., Michels, L., Kaya, M., Kollias, S. S., & Sándor, P. S. (2016) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12993 · Cited by 20
The long-term prognosis of tension-type headache
Couch, J. R. (2005) · Current Pain and Headache Reports · doi:10.1007/s11916-005-0024-5 · Cited by 19
Behavioral plus pharmacological treatment versus pharmacological treatment only for chronic migraine with medication overuse after day-hospital withdrawal
Grazzi, L., Usai, S., Prunesti, A., Bussone, G., & Andrasik, F. (2009) · Neurological Sciences · doi:10.1007/s10072-009-0065-3 · Cited by 18
Role of 2 Common Variants of 5HT2A Gene in Medication Overuse Headache
Terrazzino, S., Sances, G., Balsamo, F., Viana, M., Monaco, F., Bellomo, G., Martignoni, E., Tassorelli, C., Nappi, G., Canonico, P. L., et al. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01757.x · Cited by 18
Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraine
Sacco, S., Benemei, S., Cevoli, S., Coppola, G., Cortelli, P., Cesaris, F. D., Icco, R. D., Marco, C. M. D., Lorenzo, C. D., Geppetti, P., et al. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0966-3 · Cited by 17
Longitudinal neurofunctional changes in medication overuse headache patients after mindfulness practice in a randomized controlled trial (the MIND-CM study)
Fedeli, D., Ciullo, G., Demichelis, G., Medina, J. P., Bruzzone, M. G., Ciusani, E., Erbetta, A., Ferraro, S., Grisoli, M., Guastafierro, E., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01803-5 · Cited by 17
Medication overuse headache: A silent pandemic
Davies, P. (2011) · Pain · doi:10.1016/j.pain.2011.10.021 · Cited by 17
Treatment of chronic migraine with medication overuse: is drug withdrawal crucial?
Grazzi, L., Andrasik, F., Usai, S., & Bussone, G. (2009) · Neurological Sciences · doi:10.1007/s10072-009-0079-x · Cited by 17
Medication Overuse Headache
Kulkarni, G., Mathew, T., & Mailankody, P. (2021) · Neurology India · doi:10.4103/0028-3886.315981 · Cited by 16

Authors: Diener, H.-C., & Limmroth, V.
Affiliations: Essen University Hospital (DE)
Corresponding author: Diener, Hans-Christoph
ORCID: Limmroth, Volker
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2004-08
Volume: 3
Issue: 8
Pages: 475-483
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(04)00824-5
OpenAlex: W2115215127
Cited by: 455
References: 82
Citations by year: 2026: 6 · 2025: 13 · 2024: 12 · 2023: 18 · 2022: 20 · 2021: 16 · 2020: 22 · 2019: 19 · 2018: 19 · 2017: 15 · 2016: 19 · 2015: 20 · 2014: 23 · 2013: 26 · 2012: 26
FWCI: 2.48
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords: medication overuse headache, analgesic overuse, migraine, headache frequency, International Classification of Headache Disorders, withdrawal therapy, headache prevention
MeSH terms: Diagnosis, Differential, Headache, Humans, Prognosis, Outcome Assessment, Health Care, Headache Disorders, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Medication-overuse headache: a worldwide problem

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks